We are live on ! Find out more
PRVA icon

Privia Health

90 hedge funds and large institutions have $1.28B invested in Privia Health in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

0% more funds holding

Funds holding: 9090 (0)

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

2.31% less ownership

Funds ownership: 53.76%51.45% (-2.3%)

49% less capital invested

Capital invested by funds: $2.52B → $1.28B (-$1.24B)

Holders
90
Holders Change
Holders Change %
0%
% of All Funds
1.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
33
Reduced
21
Closed
24
Calls
Puts
Net Calls
Net Calls Change

PRVA Hedge Fund Activity: Q3 2021 in Review

90 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q3 2021, worth a combined $1.28B — down 49% from $2.52B a quarter earlier.

Fund positioning in PRVA was balanced in Q3 2021: 24 funds opened new positions, 24 closed out, 33 added to existing stakes and 21 trimmed.

The largest buyer was Bank of New York Mellon, adding an estimated $25.8M. The largest seller was Vanguard Group, cutting an estimated $85.5M.

  • 90 institutional investors held Privia Health (PRVA) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $1.28B of Privia Health stock for Q3 2021, down 49% quarter-over-quarter.
  • 24 funds opened new Privia Health positions in Q3 2021 and 24 closed out, a net change of 0 holders.
  • The largest Privia Health buyer in Q3 2021 was Bank of New York Mellon, an estimated $25.8M added.
  • The largest Privia Health seller in Q3 2021 was Vanguard Group, an estimated $85.5M sold.

Based on aggregated 13F filings for Q3 2021.